STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

IDenta Corp Posts Strong Third Quarter Financials, Highlighting Solid Balance Sheet and Growth Prospects

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags

IDenta Corp (OTCQB: IDTA) reported third quarter 2025 results showing mixed operational performance and a solid balance sheet position. Revenues rose to $427,519 in Q3 2025 from $366,870 in Q3 2024, while gross profit reached $194,038. Operating profit was $100,770 and net profit was $79,634 for Q3 2025.

Cash and cash equivalents were $604,209 at quarter end. Management highlighted continued global demand for field-detection and home diagnostic kits, a lean cost structure, expanding customer partnerships, and an expectation of revenue growth and margin improvement through 2026.

IDenta Corp (OTCQB: IDTA) ha riportato i risultati del terzo trimestre 2025 che mostrano una performance operativa mista e una solida posizione di bilancio. Le entrate sono aumentate a 427.519 dollari nel Q3 2025 rispetto ai 366.870 dollari nel Q3 2024, mentre il profitto lordo ha raggiunto 194.038 dollari. L'utile operativo è stato di 100.770 dollari e l'utile netto di 79.634 dollari per il Q3 2025. Il flusso di cassa e le disponibilità liquide ammontavano a 604.209 dollari al termine del trimestre. La direzione ha sottolineato una domanda globale continua per kit di rilevazione sul campo e diagnostici per uso domestico, una struttura dei costi snella, partnership con i clienti in espansione e una previsione di crescita dei ricavi e miglioramento delle margini attraverso il 2026.

IDenta Corp (OTCQB: IDTA) reportó los resultados del tercer trimestre de 2025, mostrando un desempeño operativo mixto y una sólida posición de balance. Los ingresos aumentaron a 427.519 dólares en el T3 2025 desde 366.870 dólares en el T3 2024, mientras que el beneficio bruto alcanzó los 194.038 dólares. El beneficio operativo fue de 100.770 dólares y el beneficio neto de 79.634 dólares para el T3 2025. Los efectivo y equivalentes de efectivo fueron 604.209 dólares al cierre del trimestre. La dirección destacó la demanda global continúa para kits de detección de campo y diagnósticos para el hogar, una estructura de costos ajustada, asociaciones con clientes en expansión y una expectativa de crecimiento de ingresos y mejora de márgenes a través de 2026.

IDenta Corp (OTCQB: IDTA)는 2025년 3분기 실적에서 혼합된 영업 성과와 건전한 대차대조표를 보였다고 발표했다. 2025년 3분기 매출은 427,519달러로 2024년 3분기 366,870달러에서 증가했고, 매출총이익은 194,038달러에 도달했다. 영업이익은 100,770달러, 순이익은 79,634달러였다. 분기 말 현금 및 현금성자산은 604,209달러였다. 경영진은 현장 탐지 및 가정용 진단 키트에 대한 글로벌 수요 지속, 간소화된 비용 구조, 확대되는 고객 파트너십, 2026년까지 매출 성장과 마진 개선에 대한 기대를 강조했다.

IDenta Corp (OTCQB : IDTA) a rapporté les résultats du troisième trimestre 2025 montrant une performance opérationnelle mixte et une position solide du bilan. Les revenus ont augmenté à 427 519 dollars au T3 2025 contre 366 870 dollars au T3 2024, tandis que le profit brut a atteint 194 038 dollars. Le résultat opérationnel s'est élevé à 100 770 dollars et le bénéfice net à 79 634 dollars pour le T3 2025. Les liquidités et équivalents étaient de 604 209 dollars à la fin du trimestre. La direction a souligné une demande mondiale continue pour les kits de détection sur le terrain et les diagnostics à domicile, une structure de coûts allégée, des partenariats clients en expansion et une attente de croissance des revenus et d'amélioration des marges d'ici 2026.

IDenta Corp (OTCQB: IDTA) meldete für das dritte Quartal 2025 Ergebnisse, die eine gemischte operative Leistung und eine solide Bilanzposition zeigen. Die Umsätze stiegen im dritten Quartal 2025 auf 427.519 USD gegenüber 366.870 USD im dritten Quartal 2024, während der Bruttogewinn 194.038 USD erreichte. Das Betriebsergebnis betrug 100.770 USD und der Nettogewinn 79.634 USD für das dritte Quartal 2025. Flüssige Mittel und Zahlungsmitteläquivalente betrugen am Quartalsende 604.209 USD. Das Management hob die weiterhin globale Nachfrage nach Feld-Erkennungs- und Heimdiagnose-Kits, eine schlanke Kostenstruktur, wachsende Kundenpartnerschaften und eine Erwartung von Umsatzwachstum und Margenverbesserung bis 2026 hervor.

IDenta Corp (OTCQB: IDTA) أبلغت عن نتائج الربع الثالث من 2025، مع عرض أداء تشغيلي مختلط ووضع قوي للميزانية. ارتفعت الإيرادات إلى 427,519 دولارًا في الربع الثالث من 2025 من 366,870 دولارًا في الربع الثالث من 2024، بينما بلغ إجمالي الربح 194,038 دولارًا. كان الربح التشغيلي 100,770 دولار والربح الصافي 79,634 دولارًا للربع الثالث من 2025. وكانت السيولة النقدية وما يعادلها 604,209 دولارًا في نهاية الربع. وأكدت الإدارة الطلب العالمي المستمر على أطقم الكشف الميداني والاختبارات التشخيصية المنزلية، وهيكلة تكاليف مرنة، وشراكات مع العملاء في توسع، وتوقعات بنمو الإيرادات وتحسن الهامش حتى عام 2026.

Positive
  • Revenue +16.5% YoY to $427,519 in Q3 2025
Negative
  • Net profit -22.2% YoY to $79,634 in Q3 2025
  • Cash down -17.9% YoY to $604,209 at Q3 2025

HOLLYWOOD, Fla., Nov. 13, 2025 /PRNewswire/ -- IDenta Corp. (OTCQB: IDTA) is a worldwide leader in the development of Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives and Unique Forensic Products in Homeland Security and Consumer Markets. Today announced a remarkable achievement for the third quarter of 2025, reporting increase in sales compared to the same period last year.

Mr. Amichai Glattstein, Chief Executive Officer, commented: "As the global demand for rapid, accurate field-testing solutions continues to expand, IDenta is poised for accelerated growth. With strong liquidity, a lean cost structure, and expanding customer partnerships, the company anticipates revenue growth and margin improvement through 2026. Our performance this year underscores IDenta's resilience and ability to adapt. We have strengthened our financial foundation, expanded our global presence, and continued delivering vital detection technologies to our partners around the world. We enter 2026 with strong momentum and a clear focus on sustainable, profitable growth".

Highlights of the Third Quarter of 2025 compared to the Third Quarter of 2024:

  • Revenues for the third quarter of 2025 were $427,519 compared to revenues of $366,870 in the third quarter of 2024.
  • Gross profit increased to $194,038 in the third quarter of 2025 compared to gross profit of $179,413 in the third quarter of 2024.
  • Operating profit is $100,770 in the third quarter of 2025 compared to $100,295 in the third quarter of 2024.  
  • Net profit for the third quarter of 2025 was $79,634 compared to net profit of $102,344 in the third quarter of 2024.  
  • Cash and cash equivalents increased to $604,209 for the third quarter of 2025 compared to $735,954 for the third quarter of 2024.

About IDenta Corp.

IDenta Corp. is a global leader in the development and supply of Field Detection and Home Diagnostics Testing Kits for Drugs & Explosives and Unique Forensic Products in the Homeland Security and Consumer Markets. IDenta develops, manufactures and distributes revolutionary products for both the professional Law and Retail markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. For more information, please visit at www.identa-corp.com and www.touch-know.com or follow us on social media.

Safe Harbor Statement 

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Company Contact Information:
Public Relations
Tel: (240) 545-6646
E: pr@identa-corp.com

Cision View original content:https://www.prnewswire.com/news-releases/identa-corp-posts-strong-third-quarter-financials-highlighting-solid-balance-sheet-and-growth-prospects-302614843.html

SOURCE IDenta Corp.

FAQ

What were IDenta (IDTA) revenues for Q3 2025 and how did they compare to Q3 2024?

Q3 2025 revenue was $427,519, up from $366,870 in Q3 2024 (about +16.5% YoY).

How did IDenta's (IDTA) net profit in Q3 2025 compare to the prior year quarter?

Q3 2025 net profit was $79,634, down from $102,344 in Q3 2024 (about -22.2% YoY).

What was IDenta's (IDTA) cash position at the end of Q3 2025?

Cash and cash equivalents were reported at $604,209 for Q3 2025, down from $735,954 in Q3 2024.

Does IDenta (IDTA) expect growth after Q3 2025?

Management stated the company anticipates revenue growth and margin improvement through 2026 based on demand and partnerships.

What products drive IDenta's (IDTA) business and market focus?

IDenta develops field detection and home diagnostic testing kits for narcotics, explosives, and forensic products serving homeland security and consumer markets.
Identa Ltd Rvice

OTC:IDTA

IDTA Rankings

IDTA Latest News

IDTA Stock Data

970.94k
3.53M
Diagnostics & Research
Healthcare
Link
Israel
Jerusalem